- Home
- MAMA vs NKTX Comparison
MAMA vs NKTX Comparison
Compare MAMA & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- NKTX
- Stock Information
- Founded
- MAMA 2010
- NKTX 2015
- Country
- MAMA United States
- NKTX United States
- Employees
- MAMA N/A
- NKTX N/A
- Industry
- MAMA Specialty Foods
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- MAMA Consumer Staples
- NKTX Health Care
- Exchange
- MAMA Nasdaq
- NKTX Nasdaq
- Market Cap
- MAMA 312.9M
- NKTX 123.5M
- IPO Year
- MAMA N/A
- NKTX 2020
- Fundamental
- Price
- MAMA $8.99
- NKTX $1.75
- Analyst Decision
- MAMA Strong Buy
- NKTX Strong Buy
- Analyst Count
- MAMA 3
- NKTX 6
- Target Price
- MAMA $10.33
- NKTX $14.40
- AVG Volume (30 Days)
- MAMA 286.4K
- NKTX 491.4K
- Earning Date
- MAMA 06-03-2025
- NKTX 08-12-2025
- Dividend Yield
- MAMA N/A
- NKTX N/A
- EPS Growth
- MAMA N/A
- NKTX N/A
- EPS
- MAMA 0.11
- NKTX N/A
- Revenue
- MAMA $128,745,000.00
- NKTX N/A
- Revenue This Year
- MAMA $17.24
- NKTX N/A
- Revenue Next Year
- MAMA $9.95
- NKTX N/A
- P/E Ratio
- MAMA $81.76
- NKTX N/A
- Revenue Growth
- MAMA 17.04
- NKTX N/A
- 52 Week Low
- MAMA $5.50
- NKTX $1.31
- 52 Week High
- MAMA $9.98
- NKTX $8.23
- Technical
- Relative Strength Index (RSI)
- MAMA 72.35
- NKTX 48.04
- Support Level
- MAMA $8.12
- NKTX $1.63
- Resistance Level
- MAMA $8.53
- NKTX $1.80
- Average True Range (ATR)
- MAMA 0.32
- NKTX 0.08
- MACD
- MAMA 0.04
- NKTX -0.01
- Stochastic Oscillator
- MAMA 85.81
- NKTX 49.89
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.